Abstract
Forty-two substances having been described as potential tumor markers for ovarian cancer are reviewed regarding sensitivity, specificity, and correlation with clinical course of disease. At present, there is no reliable marker for the primary diagnosis of the vast majority of ovarian cancers. Tumor markers may however serve as adjunctive tools in monitoring ovarian cancer patients after treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.